MYD88 and Cognitive impairment: • Alleviated cognitive impairment in AD rats• Reduced Aβ deposition• Reduced TNF-α and IL-1β levels• Decreased expression of TLR4, MyD88, TRIF, and downstream effectors including NF-κB and IRF3